Format

Send to

Choose Destination
Lung Cancer. 2018 Jan;115:34-41. doi: 10.1016/j.lungcan.2017.10.015. Epub 2017 Nov 8.

Radiomics and radiogenomics in lung cancer: A review for the clinician.

Author information

1
Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, NY 11219, United States; Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States. Electronic address: rajat.thawani@case.edu.
2
Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States.
3
Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, United States.

Abstract

Lung cancer is responsible for a large proportion of cancer-related deaths across the globe, with delayed detection being perhaps the most significant factor for its high mortality rate. Though the National Lung Screening Trial argues for screening of certain at-risk populations, the practical implementation of these screening efforts has not yet been successful and remains in high demand. Radiomics refers to the computerized extraction of data from radiologic images, and provides unique potential for making lung cancer screening more rapid and accurate using machine learning algorithms. The quantitative features analyzed express subvisual characteristics of images which correlate with pathogenesis of diseases. These features are broadly classified into four categories: intensity, structure, texture/gradient, and wavelet, based on the types of image attributes they capture. Many studies have been done to show correlation between these features and the malignant potential of a nodule on a chest CT. In cancer patients, these nodules also have features that can be correlated with prognosis and mutation status. The major limitations of radiomics are the lack of standardization of acquisition parameters, inconsistent radiomic methods, and lack of reproducibility. Researchers are working on overcoming these limitations, which would make radiomics more acceptable in the medical community.

KEYWORDS:

Image analysis; Lung cancer; Radiogenomics; Radiomics

PMID:
29290259
DOI:
10.1016/j.lungcan.2017.10.015
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center